Bharat Biotech asked to provide more data on Covaxin for below 12-year-olds 0 22.04.2022 08:27 Business Standard This development comes after the Subject Expert Committee discussed recommendations for the restricted emergency of Covaxin in children aged between 2-12 years Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
